Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients
Topic / Pathology
- interventional
Objectives
Prospective, single-centre, class 2 study aimed at better characterising the immune response in the blood of AD patients. A blood sample will be taken to assess cytokine levels at baseline and at the follow-up visit 3 months after the start of treatment. The blood sample will be taken as part of the blood tests carried out for the standard follow-up of AD.
Sponsor
CHU de Nice
Investigator
Dr Thomas Hubiche
Critères d'inclusion
Patient with clinically diagnosed atopic dermatitis according to the criteria of Hanifin and Rajka. Moderate to severe defined by an Investigator's Global Assessment ³3 and eligible to systemic treatment...
Critères de non-inclusion
Patient with an infection Patient with other systemic inflammatory disease Patient with anti-inflammatory or immunosuppressive therapy Patient with a contraindication to JAK inhibitors...
Status
Ongoing
